Get the Stockscreener App
0.5847
5.59%
-0.0346
Pre-market:
.58
-0.0047
-0.80%
Klotho Neurosciences Inc stock is traded at $0.5847, with a volume of 2.15M.
It is down -5.59% in the last 24 hours and up +12.53% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.6193
Open:
$0.6375
24h Volume:
2.15M
Relative Volume:
0.67
Market Cap:
$35.89M
Revenue:
-
Net Income/Loss:
$-11.35M
P/E Ratio:
-1.2839
EPS:
-0.4554
Net Cash Flow:
$-5.51M
1W Performance:
+18.91%
1M Performance:
+12.53%
6M Performance:
+253.08%
1Y Performance:
+18.82%
1-Day Range:
$0.5807
$0.665
1-Week Range:
$0.4757
$0.665
52-Week Range:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
(833) 931-6330
Address
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.5847 | 38.01M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Klotho Neurosciences Inc. stock volume spike explainedJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
Klotho Neurosciences to acquire select assets from Turn Biotechnologies - MSN
Why Klotho Neurosciences Inc. stock appeals to analystsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Published on: 2025-10-10 05:36:46 - newser.com
Published on: 2025-10-10 04:03:17 - newser.com
Historical volatility pattern of Klotho Neurosciences Inc. visualizedWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Is Klotho Neurosciences Inc. trending in predictive chart modelsQuarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Klotho Neurosciences Announces Expiration of Letter of Intent - Eastern Progress
Klotho Neurosciences Announces Expiration Of Letter Of Intent - Barchart.com
Earnings visualization tools for Klotho Neurosciences Inc.Weekly Trade Recap & Entry Point Confirmation Alerts - newser.com
What’s next for Klotho Neurosciences Inc. stock priceExit Point & AI Driven Stock Movement Reports - newser.com
Why Klotho Neurosciences Inc. is moving todayPortfolio Gains Report & Fast Entry Momentum Trade Alerts - newser.com
Will Klotho Neurosciences Inc. stock recover after recent dropJuly 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
How strong is Klotho Neurosciences Inc. Equity Warrant stock balance sheet2025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Combining price and volume data for Klotho Neurosciences Inc.Quarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
How sentiment analysis helps forecast Klotho Neurosciences Inc. Equity WarrantProfit Target & Advanced Swing Trade Entry Alerts - newser.com
Visual trend scoring systems applied to Klotho Neurosciences Inc.2025 Price Targets & AI Driven Stock Movement Reports - newser.com
How to use a screener to detect Klotho Neurosciences Inc. breakoutsAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Is Klotho Neurosciences Inc. Equity Warrant forming a reversal pattern2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Reversal indicators forming on Klotho Neurosciences Inc. Equity Warrant stockJuly 2025 Patterns & Stock Portfolio Risk Management - newser.com
Can swing trading help recover from Klotho Neurosciences Inc. lossesJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
Klotho Neurosciences to Acquire Longevity Therapeutic Assets from Turn Biotechnologies - Contract Pharma
Using R and stats models for Klotho Neurosciences Inc. Equity Warrant forecastingPortfolio Update Report & Technical Confirmation Alerts - newser.com
Klotho Neurosciences signs LOI to acquire Turn Bio assets By Investing.com - Investing.com Nigeria
Klotho Neurosciences Signs Letter of Intent to Acquire Select As - GuruFocus
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):